348 related articles for article (PubMed ID: 11287758)
1. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
Abe K; Miyazaki M; Koji T; Furusu A; Shioshita K; Tsukasaki S; Ozono Y; Harada T; Sakai H; Kohno S
Nephron; 2001 Mar; 87(3):231-9. PubMed ID: 11287758
[TBL] [Abstract][Full Text] [Related]
2. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.
Abe K; Miyazaki M; Koji T; Furusu A; Ozono Y; Harada T; Sakai H; Nakane PK; Kohno S
Kidney Int; 1998 Jul; 54(1):120-30. PubMed ID: 9648070
[TBL] [Abstract][Full Text] [Related]
3. Intraglomerular C3 synthesis in human kidney detected by in situ hybridization.
Miyazaki M; Abe K; Koji T; Furusu A; Ozono Y; Harada T; Nakane PK; Yagame M; Endoh M; Nomoto Y; Sakai H
J Am Soc Nephrol; 1996 Nov; 7(11):2428-33. PubMed ID: 8959636
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
[TBL] [Abstract][Full Text] [Related]
5. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization.
Abe K; Miyazaki M; Koji T; Furusu A; Nakamura-Kurashige T; Nishino T; Ozono Y; Harada T; Sakai H; Kohno S
Kidney Int; 2001 Jul; 60(1):137-46. PubMed ID: 11422745
[TBL] [Abstract][Full Text] [Related]
7. Intraglomerular C3 synthesis in rats with passive Heymann nephritis.
Sasaki O; Zhou W; Miyazaki M; Abe K; Koji T; Verroust P; Tsukasaki S; Ozono Y; Harada T; Nakane PK; Kohno S; Sacks SH
Am J Pathol; 1997 Nov; 151(5):1249-56. PubMed ID: 9358750
[TBL] [Abstract][Full Text] [Related]
8. Complement activation is associated with crescent formation in IgA nephropathy.
Itami H; Hara S; Samejima K; Tsushima H; Morimoto K; Okamoto K; Kosugi T; Kawano T; Fujiki K; Kitada H; Hatakeyama K; Tsuruya K; Ohbayashi C
Virchows Arch; 2020 Oct; 477(4):565-572. PubMed ID: 32300880
[TBL] [Abstract][Full Text] [Related]
9. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.
Onda K; Ohsawa I; Ohi H; Tamano M; Mano S; Wakabayashi M; Toki A; Horikoshi S; Fujita T; Tomino Y
BMC Nephrol; 2011 Nov; 12():64. PubMed ID: 22111871
[TBL] [Abstract][Full Text] [Related]
10. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
Oren R; Laufer J; Goldberg I; Kopolovic J; Waldherr R; Passwell JH
Immunology; 1995 Dec; 86(4):575-83. PubMed ID: 8567024
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of whole glomeruli in patients with IgA nephropathy using microsieving.
Kojima S; Koitabashi K; Iizuka N; Okamoto K; Arito M; Sato T; Kurokawa MS; Suematsu N; Shibagaki Y; Yasuda T; Kimura K; Kato T
Am J Nephrol; 2014; 39(1):36-45. PubMed ID: 24434790
[TBL] [Abstract][Full Text] [Related]
12. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases.
Suzuki D; Miyata T; Nangaku M; Takano H; Saotome N; Toyoda M; Mori Y; Zhang SY; Inagi R; Endoh M; Kurokawa K; Sakai H
J Am Soc Nephrol; 1999 Dec; 10(12):2606-13. PubMed ID: 10589701
[TBL] [Abstract][Full Text] [Related]
13. Histological reappraisal of IgA nephropathy: the role of glomerular pattern of injury and mesangial complement deposition.
Obrișcă B; Mocanu V; Jurubiță R; Vrabie A; Berechet A; Lujinschi Ș; Sorohan B; Andronesi A; Achim C; Lupușoru G; Micu G; Caceaune N; Gherghiceanu M; Ismail G
BMC Nephrol; 2024 Apr; 25(1):145. PubMed ID: 38658875
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy.
Miyamoto H; Yoshioka K; Takemura T; Akano N; Maki S
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):77-86. PubMed ID: 3131958
[TBL] [Abstract][Full Text] [Related]
15. Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.
Xie X; Liu P; Gao L; Zhang X; Lan P; Bijol V; Lv J; Zhang H; Jin J
J Pathol; 2021 Jun; 254(2):159-172. PubMed ID: 33660264
[TBL] [Abstract][Full Text] [Related]
16. Immunofluorescent studies on S-protein in glomeruli from patients with IgA nephropathy.
Tomino Y; Yagame M; Eguchi K; Nomoto Y; Sakai H
Am J Pathol; 1987 Nov; 129(2):402-6. PubMed ID: 3314533
[TBL] [Abstract][Full Text] [Related]
17. Immunopathological predictors of prognosis in IgA nephropathy.
Tomino Y
Contrib Nephrol; 2013; 181():65-74. PubMed ID: 23689568
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of infiltration and activation of glomerular monocytes/macrophages in IgA nephropathy.
Ootaka T; Saito T; Soma J; Yusa A; Abe K
Am J Nephrol; 1997; 17(2):137-45. PubMed ID: 9096444
[TBL] [Abstract][Full Text] [Related]
19. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
20. Significance of glomerular deposition of C3c and C3d in IgA nephropathy.
Nakagawa H; Suzuki S; Haneda M; Gejyo F; Kikkawa R
Am J Nephrol; 2000; 20(2):122-8. PubMed ID: 10773612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
